HOUSE OF COMMONS OF CANADA
35th PARLIAMENT, 2nd SESSION

EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 46

Wednesday, March 5, 1997

ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Canadian Drug Manufacturers Association:

Leslie Dan, Chairman and CEO, Novopharm Ltd.;

Brenda Drinkwalter, President;

Jim Keon, Vice-President, Research and International Affairs;

Joseph Kerba, Vice-President, Operations, Novopharm Quebec;

Barry Sherman, Chairman and CEO, Apotex Inc.